Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Serum biomarkers for neurofibromatosis type 1 and early detection of malignant peripheral nerve-sheath tumors

  • Su-Jin Park1,
  • Birgit Sawitzki2,
  • Lan Kluwe3,
  • Victor F Mautner3,
  • Nikola Holtkamp1 and
  • Andreas Kurtz1, 4Email author
Contributed equally
BMC Medicine201311:109

DOI: 10.1186/1741-7015-11-109

Received: 27 July 2012

Accepted: 8 March 2013

Published: 23 April 2013

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
27 Jul 2012 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
23 Aug 2012 Reviewed Reviewer Report - Pierre Wolkenstein
10 Oct 2012 Reviewed Reviewer Report - Matthias Bache
1 Nov 2012 Author responded Author comments - Andreas kurtz
Resubmission - Version 3
1 Nov 2012 Submitted Manuscript version 3
3 Dec 2012 Reviewed Reviewer Report - Matthias Bache
26 Dec 2012 Author responded Author comments - Andreas kurtz
Resubmission - Version 4
26 Dec 2012 Submitted Manuscript version 4
11 Feb 2013 Reviewed Reviewer Report - Matthias Bache
28 Feb 2013 Author responded Author comments - Andreas kurtz
Resubmission - Version 5
28 Feb 2013 Submitted Manuscript version 5
2 Mar 2013 Author responded Author comments - Andreas kurtz
Resubmission - Version 6
2 Mar 2013 Submitted Manuscript version 6
4 Mar 2013 Author responded Author comments - Andreas kurtz
Resubmission - Version 7
4 Mar 2013 Submitted Manuscript version 7
Publishing
8 Mar 2013 Editorially accepted
23 Apr 2013 Article published 10.1186/1741-7015-11-109

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Berlin-Brandenburg Center for Regenerative Therapies, Charité - Universitätsmedizin Berlin
(2)
Institute for Clinical Immunology, Charité - Universitätsmedizin Berlin
(3)
Experimental Tumor Research, Phakomatoses, Department of Neurology, Universitätsklinikum Hamburg-Eppendorf
(4)
College of Veterinary Medicine, Seoul National University

Advertisement